Vicente Ces de Souza Dantas
Overview
Explore the profile of Vicente Ces de Souza Dantas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomazini B, Besen B, Santos R, Nassar Jr A, Veiga T, Campos V, et al.
Crit Care
. 2025 Jan;
29(1):4.
PMID: 39754200
Background: Limited data is available to evaluate the burden of device associated healthcare infections (HAI) [central line associated bloodstream infection (CLABSI), catheter associated urinary tract infection (CAUTI), and ventilator associated...
2.
Arns B, Kalil A, Sorio G, Boschi E, Antonio A, Antonio J, et al.
Crit Care
. 2024 Dec;
28(1):412.
PMID: 39695798
Background: Shorter courses of antimicrobial therapy have been shown to be non-inferior to longer durations for the management of several infections. However, data on critically ill patients with severe infections...
3.
Maia I, Biasi Cavalcanti A, Tramujas L, Veiga V, Oliveira J, Sady E, et al.
Br J Anaesth
. 2024 Nov;
134(3):693-702.
PMID: 39592365
Background: This study aimed to assess whether a driving pressure-limiting strategy based on positive end-expiratory pressure (PEEP) titration according to best respiratory system compliance and tidal volume adjustment increases the...
4.
Zampieri F, Westphal G, Santos M, Gomes S, Gomes J, Negrelli K, et al.
J Crit Care
. 2024 Aug;
84:154892.
PMID: 39096659
Purpose: To assess the effect of antisense therapy to block kallikrein-kinin pathway in COVID-19 patients. Material And Methods: Randomized, placebo-controlled, double blind, controlled trial enrolling hospitalized COVID-19 patients that required...
5.
Maia I, Medrado Jr F, Tramujas L, Tomazini B, Oliveira J, Sady E, et al.
Crit Care Sci
. 2024 May;
36:e20240210en.
PMID: 38775567
Background: Driving pressure has been suggested to be the main driver of ventilator-induced lung injury and mortality in observational studies of acute respiratory distress syndrome. Whether a driving pressure-limiting strategy...
6.
de Barros E Silva P, Furtado R, de Alcantara Chaud M, Macedo A, Bronhara B, Damiani L, et al.
J Thromb Thrombolysis
. 2024 May;
57(6):1031-1039.
PMID: 38762708
Therapeutic anticoagulation showed inconsistent results in hospitalized patients with COVID-19 and selection of the best patients to use this strategy still a challenge balancing the risk of thrombotic and hemorrhagic...
7.
Cidade J, Ces de Souza Dantas V, de Figueiredo Thompson A, de Miranda R, Mamfrim R, Caroli H, et al.
J Clin Med
. 2023 Apr;
12(8).
PMID: 37109370
: COVID-19 presents complex pathophysiology, and evidence collected points towards an intricate interaction between viral-dependent and individual immunological mechanisms. Identifying phenotypes through clinical and biological markers may provide a better...
8.
Landsteiner de Sampaio Amendola I, Aires Pinheiro J, Povoa P, Ces de Souza Dantas V, Serafim R
J Clin Med
. 2022 Nov;
11(22).
PMID: 36431342
The ongoing chronic use of hydroxychloroquine or chloroquine (HCQ/CQ) in rheumatic patients might impact their outcomes after a SARS-CoV-2 infection. Therefore, we sought to assess the mortality in rheumatic patients...
9.
Resuscitation fluid practices in Brazilian intensive care units: a secondary analysis of Fluid-TRIPS
de Freitas F, Hammond N, Li Y, de Azevedo L, Biasi Cavalcanti A, Taniguchi L, et al.
Rev Bras Ter Intensiva
. 2021 Jul;
33(2):206-218.
PMID: 34231801
Objective: To describe fluid resuscitation practices in Brazilian intensive care units and to compare them with those of other countries participating in the Fluid-TRIPS. Methods: This was a prospective, international,...
10.
Lopes R, de Barros E Silva P, Furtado R, Macedo A, Bronhara B, Damiani L, et al.
Lancet
. 2021 Jun;
397(10291):2253-2263.
PMID: 34097856
Background: COVID-19 is associated with a prothrombotic state leading to adverse clinical outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised with COVID-19 is unknown. We aimed to compare the...